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Introduction
The development of imaging techniques and the widespread adoption of screening programs resulted in dramatically increased incidence of ductal carcinoma in situ (DCIS), which currently accounts for about 20-25% of newly diagnosed breast cancer cases. 1 The most common clinical presentation of DCIS are mammographically visible microcalcifications. Although being present in about 30% of all breast cancers and in approximately 55% of nonpalpable breast malignancies, they are responsible for the detection of 85-95% of cases of DCIS by screening mammography. 2, 3 The microcalcifications associated with the development of DCIS arise in the lumen of the terminal ducts, by calcium production on the secretion material or on the zones of necrosis. 4 They only indirectly attest to the cell proliferation of the carcinoma, that will then progress in the ducts in an anterograde direction toward the nipple or in a retrograde direction, within the lobule. 5 The microcalcifications are commonly discontinuous, which may indicate multifocality. However, since the true multifocal DCIS is currently believed to be a relatively rare condition, they most often correspond to a single lesion extending to several ducts by contiguity. [4] [5] [6] [7] With the introduction of stereotactic minimal-invasive biopsy (core-needle or vacuumassisted) it has become possible to obtain a preoperative diagnosis of suspicious breast microcalcifications not visible on ultrasound. As most DCIS lesions are nonalpable and some are more extensive that suspected on the mammogram, evaluation of imaging-pathologic correlation by a multidisciplinary team is essential in the assessment of patients to determine their eligibility for breast conserving surgery as well as to achieve in these cases a complete excision with negative margins and good cosmetic outcomes. 8 The aim of this study was to investigate the clinical and histological features, and to evaluate the association among these findings in screen-detected DCIS found on stereotactic vacuum-assisted biopsy of suspicious microcalcifications.
Patients and methods

Screening program
Nation-wide and population-based breast cancer screening program is targeting women aged 50-69, with exclusion of females undergoing treatment or being followed-up due to breast cancer. Twoview mammography (cranio-caudal and oblique) is used as a standard screening test. High-quality analogue (screen-film) or full field digital mammography (FFDM) are both allowed in screening program in Poland. Routine round length of the program is two years. All women with radiological findings categorised as suspicious of malignancy (BIRADS 4) or highly suggested for cancer (BIRADS 5) are referred to further assessment and invasive investigations. In patients with masses ultrasound-guided core-needle or vacuum-assisted biopsy is carried out, whereas in patients with other lesions, not well seen in ultrasound, a stereotactic biopsy under digital mammography guidance is performed.
Patients
A cohort of 127 consecutive non-symptomatic patients with screen-detected DCIS diagnosed in years 2009-2014 was enrolled. All of them fulfilled the study entering criteria: BIRADS category 4 or 5 microcalcifications without mass or architectural distortion, pure DCIS found on histological examination, lack of invasion or microinvasion (≤ 1 mm in the longest diameter), absence of any other breast malignancy or border-line lesion. Median (mean, range) patient age was 60 years (59.6, 50-69). All the patients underwent the same type of minimalinvasive biopsy under the stereotactic guidance. Study was approved by the Independent Ethics Committee (UMED KB-376) and the Institutional Board (NDOK/668). Patients signed the informed consent.
Biopsy
In each case an informed consent to undergo biopsy was obtained. All the procedures were performed by one breast-dedicated radiologist (PK), in the same breast care unit, according to the same standardised protocol to assure quality control. Five specimens was the minimal number of tissue cores. Each biopsy was done under the local anaesthesia using 10 cm 3 of 1% lidocaine in two-step approach: 5 cm 3 superficially and 5 cm 3 deeply. Biopsies were completed under digital mammography guidance using a designated prone table unit (Mammotest Plus / S, Fisher Imaging, Denver, USA) with 10-G needle (EnCore Breast Biopsy System, SenoRx Inc., Irvine, CA or EnCore Enspire Breast Biopsy System, C.R. Bard Inc., Tempe, AZ).
Pathology
All hematoxylin and eosin stained slides of formalin-fixed and paraffin-embedded tissue blocks were assessed by board-certified pathologists experienced in breast cancer. In all the cases pathological examination reported pure DCIS without invasive or microinvasive component. In cases with any doubt about the origin E-cadherin immunochemistry was used to exclude a pleomorphic type of lobular carcinoma in situ. Evaluation of DCIS histology was performed according to the well-defined and widely accepted criteria.
Comedonecrosis was determined as present if the central areas of necrosis with ghost outlines of cells and cellular debris were found. Grading system was expressed by the assessment of nuclear grade (NG) categorising DCIS as low, intermediate, and high grade, based on the recommendations of the College of American Pathologists. 9, 10 Finally, all the slides were reviewed and re-evaluated by study supervising pathologist (AH) to confirm the original diagnosis of DCIS and its histological features as well as the absence of invasion or microinvasion.
Statistical analysis
Data were collected in a prospective manner and entered a computer database. Statistical analysis was performed by professional statistician (PB). Following features were investigated: patient age, DCIS nuclear grade and the presence of comedonecrosis (as described above) as well as distribution pattern and morphology of microcalcifications. With regard to distribution pattern microcalcifications were classified as clustered (< 1 cm), grouped (1-2 cm), and regional (> 2 cm). Morphological type was categorised according to Tabar classification (Figure 1-3) as powdery (cotton ball-like: indistinct, amorphous), crushed stone-like (pleomorphic), and casting-type (linear, branching).
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Mammographic appearance was assessed before biopsy (without knowledge of the histopathological diagnosis) by two board-certified radiologists with special expertise in breast imaging (double reading) and then reviewed and re-evaluated by study supervising radiologist (PK) using analogue microfocus magnification techniques in orthogo- nal planes or, in cases of FFDM, on-screen magnification. Baseline characteristics are presented in Table 1 . Association between investigated variables was analysed using Pearson's chi-square test. P values less than 0.05 were considered statistically significant.
Results
Microcalcifications type -distribution
84% (n = 16) of powdery microcalcifications were clustered, 16% (3) were grouped, while none had regional distribution. Considering crushed stonelike and casting-type morphology 75% (61) and 30% (8) of microcalcifications were clustered, 20% (16) and 44% (12) were grouped, 5% (4) and 26% (12) were casting-type, respectively. None of regional microcalcifications had powdery morphology, 36% (4) were crushed stone-like, and 64% (7) were casting-type. To sum up, powdery microcalcifications were most often clustered, never regional. Similarly, just one-fourth of crushed stonelike microcalcifications were grouped or regional. Clustered microcalcifications were most rarely of casting-type while regional were most commonly. The association between morphology and distribution of microcalcifications was of very high statistical significance (t1 X-squared = 25.281, df = 4, P = 4.416e-05) ( Table 2) .
Microcalcifications type -nuclear grade
All over 74% (14) of powdery microcalcifications revealed DCIS with low NG, 16% (3) intermediate, and 10% (2) high NG. Crushed stone-like microcalcifications were related to low NG in 58% (47), intermediate in 33% (27) , and high in 9% (7). In contrast, 33% (9) of casting-type microcalcifications had high NG DCIS, 30% (8) (8), crushed stone-like in 62% (37), and casting-type in 25% (15) of cases. Neither patient age nor the presence of comedonecrosis was significantly related to morphology of microcalcifications (t1 X-squared = 1.0293, df = 2, P = 0.5977; t1 X-squared = 0.63551, df = 2, P = 0.7278; respectively).
Microcalcifications distribution -nuclear grade
In 64% (54) of clustered microcalcifications low NG DCIS was found, whereas intermediate and high NG DCIS in 27% (23) and 9% (8), respectively. Grouped microcalcifications revealed low, intermediate and high NG DCIS in 45% (14) , 39% (12), and 16% (5) of cases while regional microcalcifications in 27% (3), 27% (3), and 46% (5), respectively. 76% (54) and 60% (23) of DCIS with low and intermediate NG were presenting as clustered microcalcifications, 20% (14) and 32% (12) as grouped, and 4% (3) and 8% (3) as regional, respectively. Among patients with high NG DCIS 44% (8) had clustered, while 28% (5) each had grouped and regional microcalcifications. Summarising, low NG DCIS was the most common in clustered microcalcifications and very rare in regional, where high NG DCIS was the most often, being found in nearly half of cases. The association between distribution of microcalcifications and NG of DCIS was statistically significant (t1 X-squared = 13.233, df = 4, P = 0.01019) ( Table 3) .
Microcalcifications distribution -comedonecrosis
In 48% (41) of patients with clustered, 61% (19) with grouped and 82% (9) with regional microcalcifications DCIS with comedonecrosis was found. Among patients with non-comedo DCIS 76% (44) had clustered, 21% (12) had grouped, and 3% (2) had regional microcalcifications. 59% (41) of DCIS with comedonecrosis was presenting as clustered microcalcifications, while 28% (19) and 13% (9) as grouped and regional. In summary, three-fourths of patients without comedonecrosis had clustered microcalcifications while in the vast majority of patients with regional microcalcifications DCIS with comedonecrosis was diagnosed. The association between distribution of microcalcifications and the presence of comedonecrosis was close but did not reach the statistical significance (t1 X-squared = 5.2275, df = 2, P = 0.07326) ( Table 4 ).
Microcalcifications distribution -patient age
All over 58% (49) of patients with clustered, 39% (12) with grouped, and 55% (6) with regional microcalcifications were 50-60 years old. Considering these younger patients (50-60), 73% (49), 18% (12) , and 9% (6) had clustered, grouped and regional microcalcifications, respectively. Among older ones (61-69) clustered microcalcifications were found in 60% (36) while grouped and regional in 32% (19) and 8% (5), respectively. Patient age was not sig- nificantly related to the distribution of microcalcifications (t1 X-squared = 3.2839, df = 2, P = 0.1936).
Nuclear grade -comedonecrosis
In 94% (17) (18), and 49% (34) of cases, respectively. In summary, almost all the patients with high NG DCIS had comedonecrosis while just less than half of others. In almost all the patients without comedonecrosis DCIS of low or intemediate NG was found. The association between NG and the presence of comedonecrosis was statistically significant (t1 X-squared = 13.604, df = 2, P = 0.001112) ( Table 5 ).
Nuclear grade -patient age
Younger patients (50-60) had low, intermediate, and high NG DCIS in 57% (38), 28% (19) , and 15% (10), while older women (61-69) in 55% (33), 32% (19) , and 13% (8), respectively. In cases of high, intermediate, and low NG DCIS 56% (10), 50% (19) , and 54% (38) of patients were in younger age. Patient age was not significantly related to NG of DCIS (t1 X-squared = 0.18908, df = 2, P = 0.9098).
Comedonecrosis -patient age
Comedonecrosis was present in 54% (36) of younger patients and in 55% (33) of those aged 61-69 years. When comedonecrosis was absent 53% (31) of patients were 50-60 years old. Similarly, among patients with comedonecrosis 52% (36) was in younger group. The association was not significant (t1 X-squared = 0, df = 1, P = 1). Significance level of correlation between investigated variables is presented in Table 6 .
Discussion
Surgery, sometimes followed by radiotherapy in cases with breast conservation, remains the treatment of choice in DCIS patients. Since it is highly favourable disease, there is no difference in mortality rate regardless of which treatment is chosen. 12 On the other hand, the extent of surgical intervention and the need of postoperative radiotherapy depend on some well-defined factors known to be important in predicting of local recurrence. The most significant and independent variables are quantified by the University of California/ Van Nuys Prognostic Index (USC/VNPI), which is widely used in clinical practice. USC/VNPI is a numerical algorithm combining the following prognostic factors: age at diagnosis (older age is better), tumour size (smaller size is better), surgical margin width (wider margin is better), NG (lower grade is better), and the presence or absence of comedonecrosis (no necrosis is better). Each of the four predictors (NG and comedonecrosis both determine pathologic classification) is scored 1 (the most favourable), 2, or 3 (the least favourable), and then added together to give an overall score, ranging from a low of 4 (least likely to recur) to a high of 12 (most likely to recur). 12 However, not all these variables are available before operation (e.g. microscopic lesion diameter, surgical margin width). Moreover, some of features available before surgery can be underestimated in specimens from minimal-invasive biopsy (e.g. low/intermediate nuclear grade, absence of comedonecrosis) and eventually upgraded in the final examination of postoperative specimen. It would be helpful in surgical treatment planning if the histological characteristics could be predicted from the mammogram, particularly from the type and distribution of microcalcifications, which are the most common imaging presentation of DCIS.
There are conflicting reports on whether the histological features of DCIS can be estimated by the pattern of microcalcifications found on mammography. Dinkel et al. found that linear branching microcalcifications tended to be associated with higher pathological grading. However, correlation was poor and not statistically significant. 13 Also in a series of Slanetz and co-workers (75 cases, 62 with calcifications alone) histological grade of DCIS could not be accurately determined prospectively based on the mammographic appearance of microcalcifications. 14 In contrast, in a study of Holland and Hendriks well-differentiated DCIS was most commonly associated with multiple clusters of fine granular microcalcifications while poorly differentiated DCIS usually appeared on the mammogram as either linear branching or as coarse granular microcalcifications. 15 It corresponds to our observation that low NG DCIS is usually found in clustered microcalcifications of crushed stone-like or powdery type whereas high NG DCIS is most common in casting type microcalcifications with regional distribution.
Results of more recent studies support these findings. In the large dataset consisting of 1783 DCIS (Sloane Project) casting-type microcalcifications were more frequently seen in the higher grade of DCIS, occurring in 58% of high grade while in 26% of low grade cases. Moreover, casting-type microcalcifications were increasingly common with increasing lesion size. 16 These associations were of high statistical significance (P < 0.001). De Roos et al. reported significant association between linear microcalcifications and high grade (P < 0.001) as well as between fine granular type and low grade of DCIS (P < 0.05). 8 Barreau et al. studied a large cohort of 909 cases and found that granular or linear branching type and a number of microcalcifications higher than 20 were correlated with high grade of DCIS and the presence of comedonecrosis. 17 Evans et al. noticed that when the comedonecrosis was present following features were seen more commonly: abnormal mammogram (95% vs. 7%, P < 0.001), mammogram with calcifications (96% vs. 61%, P < 0.001), calcifications with a ductal distribution (80% vs. 45%, P < 0.005), and rod-shaped calcifications (83% vs. 45%, P < 0.001). In contrast, DCIS without comedonecrosis was associated with mammogram without calcifications (39% vs. 4%, P < 0.001) and predominantly punctate calcifications (36% vs. 13%, P < 0.05). 18 In a series of Stomper and Connolly predominantly linear calcifications were present in 47% of DCIS with comedonecrosis compared to 18% of DCIS without comedonecrosis (P = 0.01) while the predominantly granular calcifications in 53% and 82% (P = 0.01), respectively. 19 Mammogram with microcalcifications is the most common imaging appearance of DCIS. Nevertheless, in some cases calcifications are not present. Interesting issue is to compare histological characteristics of calcified and non-calcified DCIS. As mentioned above, Evans and colleagues found that non-calcified DCIS was less commonly associated with comedonecrosis. 18 Tang et al. reported that comedo DCIS had higher frequency of histologically seen calcifications in the ducts, however, when compared to other types it was easier to detect on ultrasound with not significant differences on mammography and MRI. 20 Slanetz et al. noticed that DCIS presenting on mammography as only a mass was usually well-differentiated. 14 In contrast, Cho et al. observed that 59% of non-calcified DCIS lesions were high grade or comedonecrosis type. 21 Supporting this finding, in numerous recent studies the presence of accompanying mass was related to the increased risk of invasive ductal component, which can reflect more aggressive behaviour of DCIS. [22] [23] [24] [25] In the series of Rauch et al. DCIS more frequently visible on sonography was ER-negative type, which also tended to be larger, was more likely to be high grade (93% vs. 44%, P < 0.0001) and associated with comedonecrosis (64% vs. 29%, P < 0.0001). 26 Considering screen-detected DCIS, the presence of calcifications seems to be related to less favourable histology and features associated with more aggressive behaviour. In the analysis of 217 DCIS cases in 212 asymptomatic patients by Mun et al. high nuclear grade (P < 0.05), comedonecrosis (P < 0.001), and the presence of HER2/neu oncogene (P < 0.001) were more common in the calcified lesions. 27 Similarly, Kim et al. noticed that calcified DCIS was significantly more often HER2-positive than ERpositive or triple-negative. Histopathologically, HER2-positive DCIS and triple-negative DCIS were more commonly associated with high nuclear grade and comedonecrosis when compared to ERpositive DCIS. 28 In the era of screening programmes, advanced diagnostic tools, image-guided minimal-invasive biopsies and oncoplastic surgery a very close cooperation in multidisciplinary team is essential for the optimum management of breast cancer patients. The correlation between pattern of mammographic microcalcifications and histological features related to more aggressive disease can be helpful in optimal surgery planning in patients with screen-detected DCIS, with regard to the extent of breast intervention and the consideration of synchronous sentinel node biopsy.
